Retreatment with Brentuximab Vedotin for CD30+ Cutaneous T-cell Lymphoma and Lymphomatoid Papulosis.
SkinmedPub Date : 2024-12-31eCollection Date: 2024-01-01
David M Weiner, Daniel J Lewis
{"title":"Retreatment with Brentuximab Vedotin for CD30+ Cutaneous T-cell Lymphoma and Lymphomatoid Papulosis.","authors":"David M Weiner, Daniel J Lewis","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"489-490"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skinmed","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}